“CONTEMPORARY NEUROGENETICS: FROM GENOME TO THERAPY”
24 September 2026
| 07:20–08:20 | PARTICIPANT REGISTRATION (60 minutes) | |
|---|---|---|
08:20–09.00 PLENARY SESSION (Part 1). Amir Temur Grand Hall SECTION No. 1. GENOME: from molecular diagnosis to understanding disease mechanisms Session moderators: Rakhimbaeva G.S., Tuychibaeva N.M., Dr. Ali Torabi Participating countries: Uzbekistan, Iraq |
||
| 08:20–08.40 | Gafurov Bakhtiyor Gafurovich (Uzbekistan) | Autoimmune pathology of the nervous system and myasthenia (recorded) (20 minutes) |
| 08.40-09.00 | Prof. Khalaf Gargary (Iraq) | Autism Spectrum Disorder: A Pediatrician’s Approach to Genetics and Early Intervention (recorded) (20 minutes) |
09:00–09:30 OPENING CEREMONY. Amir Temur Grand Hall CONFERENCE OPENING Session moderators: Shamansurov Sh.Sh., Nadyrkhanova N.S., Ilyasov A.B. |
||
| 09:00–09:05 | Adilov Eldor Erkinovich (Uzbekistan) | Welcome address by the Minister of Health of the Republic of Uzbekistan (5 minutes) |
| 09:05–09:10 | Nadyrkhanova Natalya Suratovna (Uzbekistan) | Welcome address by the Director of the Republican Specialized Scientific and Practical Medical Center for Maternal and Child Health, Professor, DSc (5 minutes) |
| 09:10–09:15 | Shamansurov Shaanvar Shamuradovich (Uzbekistan) | Welcome address by the Chair of the Association of Pediatric Neurologists of Uzbekistan and Head of the Department of Pediatric Neurology at CRPKMR, Professor, DSc (5 minutes) |
| 09:15–09:20 | Sharipova Madina Karimovna (Uzbekistan) | Welcome address by Uzbekistan’s leading specialist in medical genetics and Associate Professor of the Department of Faculty Pediatrics, DSc (5 minutes) |
| 09:20–09:25 | Rakhimbaeva Gulnara Sattarovna (Uzbekistan) | Welcome address by the Head of the Department of Neurology and Medical Psychology at Tashkent State Medical University, Professor, DSc |
| 09:25–09:30 | Tuychibaeva Nodira Miratalievna (Uzbekistan) | Welcome address by the Chair of the Association of Clinical Neurophysiologists and Medical Geneticists of Uzbekistan, Professor, DSc (5 minutes) |
09:30–13.30 PLENARY SESSION (Part 2). Amir Temur Grand Hall SECTION No. 1. GENOME: from molecular diagnosis to understanding disease mechanisms Session moderators: Rakhimbaeva G.S., Tuychibaeva N.M., Dr. Ali Torabi Participating countries: Uzbekistan, United Kingdom, Türkiye, France, Kazakhstan |
||
| 09.30-09.50 | Henry Holden (United Kingdom) | Neurogenetics in 2026: how genomic technologies are transforming clinical neurology (recorded) (20 minutes) |
| 09:50–10.10 | Shamansurov Shaanvar Shamuradovich (Uzbekistan) | Genetic factors in autism spectrum disorder and speech development disorders (20 minutes) |
| 10:10–10:30 | Dr. Andoni Urtizberea (France) | Inherited neuromuscular diseases: from phenotype to genotype (recorded) (20 minutes) |
| 10:30–10:50 | Rakhimbaeva Gulnara Sattarovna (Uzbekistan) | Pompe disease: aspects of disease-modifying therapy (20 minutes) |
| 10:50–11:10 | Dr. Ali Torabi (Türkiye) | From symptom to gene: the diagnostic pathway for inherited neurogenetic diseases (20 minutes) |
| 11:10–11:30 | Ilyasov Aziz Bakhtiyarovich (Uzbekistan) | Genetic diagnosis before and after birth: opportunities for prenatal and neonatal screening in the Republic of Uzbekistan (20 minutes) |
| 11:30–11:50 | COFFEE BREAK (20 minutes) | |
| 11:50–12:10 | Kayyrzhanov Rauan Bogdanovich (Kazakhstan) | Ten lessons learned from the study of rare diseases (recorded) (20 minutes) |
| 12:10–12:30 | Tuychibaeva Nodira Miratalievna (Uzbekistan) | Epileptic syndromes in patients with chromosomal rearrangements: the clinical and neurophysiological spectrum (20 minutes) |
| 12.30–12:50 | Dr. Ali Torabi (Türkiye) | Molecular genetic technologies in prenatal diagnosis and reproductive medicine (20 minutes) |
| 12.50-13.10 | Tekebaeva Latina Ayzhanovna (Kazakhstan) | White matter pathology: clinical observations (20 minutes) |
| 13.10-13.30 | Meruert Sayfullakyzy (Kazakhstan) |
MRI patterns of leukodystrophies: from neuroimaging to genetic diagnosis (20 minutes) |
| 13:30–14:30 | LUNCH (60 minutes) | |
| 13.30-14.30 | Round table: “SMA WITHOUT AGE LIMITS: CONTINUITY OF PEDIATRIC AND ADULT CARE” (for invited participants) | |
14:30–16:30 SECTION No. 2. Amir Temur Grand Hall SMA IN THE NEW THERAPEUTIC REALITY: ACHIEVEMENTS, CHALLENGES AND PROSPECTS Session moderators: Tekebaeva L.A., Shamsiddinova M.A., Shagiyasova D.A. Participating countries: Uzbekistan, France, Kazakhstan, Georgia, Azerbaijan |
||
| 14:30–14:50 | Dr. Andoni Urtizberea (France) | Pathogenetic therapy for adults with SMA: when to start and when to stop? (recorded) (20 minutes) |
| 14:50–15:10 | Tekebaeva Latina Ayzhanovna (Kazakhstan) | Management strategy for patients with SMA in Kazakhstan: achievements, barriers and prospects (20 minutes) |
| 15.10-15.30 | Ayten Mamatbeyli (Azerbaijan) | Management strategy for patients with SMA in Azerbaijan: achievements, barriers and prospects (recorded) (20 minutes) |
| 15.30-15.50 | Shamsiddinova Markhabo Anvarovna (Uzbekistan) | Management strategy for patients with SMA in Uzbekistan: achievements, barriers and prospects (20 minutes) |
| 15.50–16:10 | Shchugareva Lyudmila Mikhaylovna (Russia) | Spinal muscular atrophy: new data on sensory neuropathies, pain sensitivity, vestibular dysfunction and oculomotor disorders. What should a practitioner know? (recorded) (20 minutes) |
| 15:10–15:30 | Makhmudov Abror Saidmusaevich (Uzbekistan) | Standards for resuscitation care for children with SMA (20 minutes) |
| 15:30–15:50 | Tinatin Tkemaladze (Georgia) | From the SMN1 gene to a clinical decision: contemporary approaches to the molecular diagnosis of SMA (recorded) (20 minutes) |
| 15.50-15.55 | Esnazarova Sayora Nietbaevna (Uzbekistan) | Regional experience in managing patients with SMA in the Republic of Uzbekistan: Republic of Karakalpakstan (5 minutes) |
| 15.55-16.00 | Usmanova Dilnoza Mirolim kizi (Uzbekistan) | Regional experience in managing patients with SMA in the Republic of Uzbekistan: Andijan Region (5 minutes) |
| 16.00-16.05 | Khamdamov Nurullo Khayrullo ugli (Uzbekistan) | Regional experience in managing patients with SMA in the Republic of Uzbekistan: Namangan Region (5 minutes) |
| 16.05-16.10 | Ismatova Sokhiba Ibotovna (Uzbekistan) | Regional experience in managing patients with SMA in the Republic of Uzbekistan: Kashkadarya Region (5 minutes) |
| 16.10-16.15 | Fayzullaeva Dilfuza Sobirkhonovna (Uzbekistan) | Regional experience in managing patients with SMA in the Republic of Uzbekistan: Samarkand Region (5 minutes) |
| 16.15-16.20 | Kholmatov Mirzaolim Fozilzhon ugli (Uzbekistan) | Regional experience in managing patients with SMA in the Republic of Uzbekistan: Fergana Region (5 minutes) |
| 16.20-16.30 | Moderators | Discussion. Summary of Day One (10 minutes) |
25 September 2026
08:30–10.10 SECTION No. 3. Amir Temur Grand Hall PRENATAL DIAGNOSIS: FROM GENETIC RISK TO REPRODUCTIVE CHOICE Session moderators: Ilyasov A.B., Kurbanova V.V., Kutlymuratova F.K. Participating countries: Uzbekistan, Azerbaijan |
||
|---|---|---|
| 08:30–08:50 | Kutlymuratova Feruza Kalbaevna (Uzbekistan) | From familial genetic diagnosis to the prenatal diagnosis of monogenic diseases (20 minutes) |
| 08:50–09:10 | Sardarova Elnara (Azerbaijan) | Genetic anomalies of central nervous system development: prenatal MRI diagnosis (recorded) (20 minutes) |
| 09:10–09:30 | Kurbanova Vusala Vudadievna (Uzbekistan) | Central nervous system malformations: opportunities offered by contemporary prenatal diagnosis (20 minutes) |
| 09:30–09:50 | Turdieva Dinara Shavkatovna (Uzbekistan) | Fetal neural tube defects: contemporary approaches to the prenatal diagnosis of spina bifida (20 minutes) |
| 09.50-10.10 | Sardarova Elnara (Azerbaijan) | Congenital central nervous system malformations of genetic origin: radiological signs and differential diagnosis (recorded) (20 minutes) |
10:10–12.50 SECTION No. 4. Amir Temur Grand Hall EPILEPSY AND AUTISM: AT THE INTERSECTION OF GENETICS AND NEURODEVELOPMENT Session moderators: Saushev D.A., Vorontsova E.O., Omonova U.T. Participating countries: Uzbekistan, Kazakhstan, Russia, Azerbaijan |
||
| 10:10–10:30 | Utebekov Zhasulan Ergalievich (Kazakhstan) | Genetic factors and the effectiveness of surgical treatment for drug-resistant epilepsy: the first experience of clinical genetic analysis in Kazakhstan (20 minutes) |
| 10:30–10:50 | Saushev Dmitriy Aleksandrovich (Russia) | Genetics of structural forms of epilepsy (20 minutes) |
| 10:50–11:10 | Lyatifova Gyunel Umud (Azerbaijan) | Developmental and epileptic encephalopathies: from genetic diagnosis to personalized management (recorded) (20 minutes) |
| 11:10–11:30 | Omonova Umida Tulkinovna (Uzbekistan) | Contemporary approaches to autism spectrum disorders (20 minutes) |
| 11.30-11.50 | Vorontsova Ekaterina Olegovna (Russia) | X-linked diseases: unexpected findings in whole-genome sequencing (20 minutes) |
| 11.50-12.10 | Saushev Dmitriy Aleksandrovich (Russia) | Causes of negative DNA test results in epileptology (20 minutes) |
| 12.10-12.30 | Gubaydulina Kamila Ravilevna (Uzbekistan) | Clinical effectiveness of whole-exome sequencing in patients with epilepsy: the first experience in Uzbekistan (20 minutes) |
| 12:30–12:50 | Guseynli Yagut Salmanovna (Azerbaijan) | Key principles of the ketogenic diet and innovative treatments for children with GLUT1 deficiency syndrome (recorded) (20 minutes) |
| 12:50–13:10 | COFFEE BREAK (20 minutes) | |
13:10–15.40 SECTION No. 5. Amir Temur Grand Hall NEUROGENETIC DISEASES: FROM GENOME TO CLINICAL DECISION-MAKING Session moderators: Mirsagatova M.B., Akhmedov I.R., Gubaydulina K.R. Participating countries: Uzbekistan, Kyrgyzstan, Azerbaijan |
||
| 13.10–13:30 | Tagieva Medina (Azerbaijan) | Clinical and genetic spectrum of Duchenne muscular dystrophy in Azerbaijan: the first national data (recorded) (20 minutes) |
| 13:30–13:50 | Shagiyasova Zhamilya Akilovna (Uzbekistan) Shamsiddinova Markhabo Anvarovna (Uzbekistan) |
One family, different manifestations: experience in the diagnosis and treatment of glycogen storage disease type II (20 minutes) |
| 13:50–14:10 | Ismailova Aziza Murtabekovna (Kyrgyzstan) | A clinical case of Nabais Sa-de Vries syndrome type 2 caused by a pathogenic variant in the SPOP gene (20 minutes) |
| 14:10–14:30 | Akhmedov Ilkhom Rakhimdzhanovich (Uzbekistan) | Duchenne muscular dystrophy in Uzbekistan: from molecular diagnosis to a national registry (20 minutes) |
| 14:30–14:50 | Khamdamova Yokutkhon Sirozhiddinovna (Uzbekistan) | Molecular genetic profile of Wilson disease in Uzbekistan: the spectrum of ATP7B gene variants (20 minutes) |
| 14:50–15:10 | Mirsagatova Malika Bakhodirovna (Uzbekistan) | Plexiform neurofibromas in neurofibromatosis type 1: a clinical case series (20 minutes) |
| 15:10–15:30 | Kholmatov Mirzaolim Fozilzhon ugli (Uzbekistan) | Microstructural chromosomal rearrangements in neurodevelopmental disorders: clinical observations (20 minutes) |
| 15.30-15.40 | Conference summary and closing (10 minutes) | |
“FROM VARIANT TO DIAGNOSIS: practical interpretation of molecular genetic studies in neurogenetic and orphan diseases”
26 September 2026
Venue: Uzbekistan, Tashkent, Republican Specialized Scientific and Practical Medical Center for Maternal and Child Health, Administration Building, 1st floor, Assembly Hall, 132A Mirzo Ulugbek Street
Organizers: Ministry of Health of the Republic of Uzbekistan · Republican Specialized Scientific and Practical Medical Center for Maternal and Child Health · Association of Clinical Neurophysiologists and Medical Geneticists of Uzbekistan
Lead experts: Dr. Ali Torabi, Tuychibaeva N.M., Shamsiddinova M.A., Ganiev B.B.
Participants: medical geneticists and neurologists
Number of participants: 50 people
Participation requirements: basic knowledge of medical genetics, a laptop with internet access, knowledge of English and prior registration (according to the list)
Pre-registration contact: Bobur Bakhtiyarovich Ganiev, tel. +998 (99) 860-98-60 (message via Telegram); registration closes on 15 September 2026.
